Richard J. Fehir, Ph.D. Joins Bergeson & Campbell, P.C. as Senior Chemist for Regulatory Science
On April 13, 2026, Bergeson & Campbell, P.C. (B&C) and The Acta Group (Acta) proudly announced the addition of Richard J. Fehir, Ph.D., as their new Senior Chemist and Regulatory Scientist. With a distinguished career spanning 17 years at the U.S. Environmental Protection Agency (EPA), Dr. Fehir brings a wealth of knowledge and experience in environmental science and regulatory policies. His career at the EPA has equipped him with extensive insight into the regulatory frameworks set out by the Toxic Substances Control Act (TSCA), Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), and the Pesticide Registration Improvement Act (PRIA).
Dr. Fehir's remarkable journey in the field of regulatory science began with a focus on fostering scientific innovations that align with public and environmental safety. His leadership at the EPA was characterized by his commitment to excellence and a proactive approach towards regulatory compliance, contributing immensely to shaping the substance approval processes under these critical legislative frameworks. Rick's deep technical understanding, paired with his mastery of organizational and policy dynamics, ensures he will be pivotal in helping B&C and Acta's clients navigate complex regulatory landscapes effectively.
Lynn L. Bergeson, the Managing Partner at B&C, expressed enthusiasm regarding Dr. Fehir's joining the team. She stated, "Rick's addition to our science bench is fantastic. He deploys his deep technical understanding of the science underpinning regulatory submissions and his seasoned mastery of the organizational and policy factors shaping regulatory outcomes to assist clients in achieving their commercial goals." His expertise spans various domains, including industrial chemicals, pesticides, antimicrobials, and nanomaterials – elements critical to advancing numerous products within the chemical sector.
As both B&C and Acta are led by a team of seasoned EPA alum, Dr. Fehir's unique perspective and robust background add an unmatched wealth of experience to their collective force. The firms are known not only for their profound regulatory knowledge but also for their clarity in assisting clients to comply with regulations while maintaining a competitive edge. Clients benefit from a comprehensive approach that emphasizes both scientific integrity and practical application, particularly during product development and approval phases.
With regulatory landscapes continually evolving, Dr. Fehir's integration into B&C and Acta underscores the firms' commitment to providing empirical solutions and strategic guidance on regulatory matters. This alignment aims at fostering client relationships, ensuring compliance, and facilitating successful product market penetration. Clients can leverage Dr. Fehir's expertise to optimize their strategies in product registration and compliance, thus reinforcing their operational success.
For more details on B&C's capabilities in assisting organizations with compliance and regulatory issues, visitors to their website can explore B&C's TSCA and FIFRA practice areas, showcasing their adeptness in formulating client-oriented solutions that meet regulatory standards efficiently. Bergeson & Campbell, P.C. focuses on industrial, agricultural, and specialty chemical product approval and regulation, while The Acta Group specializes in comprehensive global chemical registration and compliance strategies, reinforcing their standing as leaders in the consulting field. As the regulatory environment becomes increasingly scrutinized, the strategic addition of experts like Dr. Fehir signifies B&C and Acta's proactive stance in navigating these challenges to better serve their clients across diverse sectors.